AIDS drug approved.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000503:physiopathology; D000995:Antitubercular Agents / Q000627:therapeutic use*; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy* / Q000503:physiopathology; D017828:Rifabutin; D012294:Rifamycins / Q000627:therapeutic use*
D000995:Antitubercular Agents; D012294:Rifamycins; D017828:Rifabutin